Showing results (461-470 of 589) with videos related to
Sort By:
Pageof 59
International Journal of Radiation Oncology, Biology, Physics|April 1, 1996
Demonstration of brachytherapy boost dose-response relationships in glioblastoma multiformeP K Sneed, K R Lamborn, D A Larson, et al.Neuro-Oncology|May 12, 2004
Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiformeDavid A Larson, Jeffrey M Suplica, Susan M Chang, et al.International Journal of Radiation Oncology, Biology, Physics|December 3, 2002
Phase II study of high central dose Gamma Knife radiosurgery and marimastat in patients with recurrent malignant gliomaDavid A Larson, Michael Prados, Kathleen R Lamborn, et al.Neurosurgery|May 1, 1995
Large effect of age on the survival of patients with glioblastoma treated with radiotherapy and brachytherapy boostP K Sneed, M D Prados, M W McDermott, et al.World Journal of Surgery|May 22, 2016
A Positive Node on Ultrasound-Guided Fine Needle Aspiration Predicts Higher Nodal Burden Than a Positive Sentinel Lymph Node Biopsy in Breast CarcinomaM R Boland, R Ni Cearbhaill, K Fitzpatrick, et al.Journal of Neuro-Oncology|February 27, 2018
Salvage therapy outcomes for atypical meningiomaWilliam C Chen, Jared Hara, Stephen T Magill, et al.British Journal of Cancer|March 20, 2003
Elevated expression and altered processing of fibulin-1 protein in human breast cancerL M Greene, W O Twal, M J Duffy, et al.Anticancer Research|May 22, 2004
Expression and prognostic relevance of Mcl-1 in breast cancerL O'Driscoll, D Cronin, S M Kennedy, et al.Neurosurgery|August 16, 2011
Neurosurgical management and prognosis of patients with glioblastoma that progresses during bevacizumab treatmentAaron J Clark, Kathleen R Lamborn, Nicholas A Butowski, et al.British Journal of Cancer|July 7, 2011
Functional and prognostic relevance of the homeobox protein MSX2 in malignant melanomaG Gremel, D Ryan, M Rafferty, et al.Pageof 59